Avances enartritis reumatoide
145
5. Carmona, L.; Gonzalez-‐Alvaro, I.; Balsa, A.; Angel Belmonte, M.; Tena, X.; Sanmarti, R.
Rheumatoid arthritis in Spain: occurrence of extra-‐articularmanifestations and estimates
of disease severity. AnnRheumDis62, 897-‐900(2003).
6. Sociedad Española de Reumatología. Estudio EPISER: Prevalencia de las enfermedades
reumáticas en lapoblaciónespañola.Merck, Sharp
&
DohmeEspaña; 2001.
7. Carbonell J.; Cobo T.; Balsa A.; Descalzo M. A.; Carmona L.The incidence of rheumatoid
arthritis inSpain: results fromanationwideprimary care registry. Rheumatology (Oxford)
47, 1088-‐1092(2008).
8. Sanmartí, R.; Ruiz-‐Esquide, V.;Hernández,M. V. RheumatoidArthritis: AClinical Overviewof
NewDiagnosticandTreatmentApproaches. CurrTopMedChem13, 698-‐704(2013).
9. VanVollenhoven, R. F. Rheumatoidarthritis in2012: Progress inRAgenetics, pathology and
therapy. NatRevRheumatol 9, 70-‐72(2013).
10. Carmona, L.; Cross, M.;Williams, B.; Lassere, M.;March, L. Rheumatoid arthritis. Best Pract
ResClinRheumatol 24, 733-‐745(2010).
11. MacGregor, A. J.; Snieder, H.; Rigby, A. S.; Koskenvuo, M.; Kaprio, J.; Aho, K. et al.
Characterizing the quantitative genetic contribution to rheumatoid arthritis using data
fromtwins. ArthritisReum43, 30-‐37(2000).
12. Bax, M.; Heemst, J. V.; Huizinga, T. W. J.; Toes, R. E. M. Genetics of rheumatoid arthritis:
what havewe learned?.Immunogenetics63, 459-‐466(2011).
13. Bowes, J.; Barton, A. Recent advances in thegeneticsof RAsusceptibility. Rheumatology47,
399-‐402(2008).
14. Raychaudhuri,S.; Sandor, C.; Stahl, E. A.;Freudenberg, J.; Lee, H. S.; Jia, X. et al. Five amino
acids in threeHLAproteins explainmost of theassociationbetweenMHCandseropositive
rheumatoidarthritis. NatureGenetics44, 291-‐296(2012).
15. Gibofsky, A. Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid
arthritis.AmJManagCare18(13Suppl), S295-‐302(2012).
16. Ding, B.; Padyukov, L.; Lundström, E.; Seielstad, M.; Plenge, R. M.; Oksenberg, J. R.; et al.
Different patterns of associations with anti-‐citrullinated protein antibody-‐positive and
anti-‐citrullinated protein antibody-‐negative rheumatoid arthritis in the extended major
histocompatibilitycomplex region. ArthritisRheum60, 30-‐38(2009).
17. Varadé, J.; Figueredo, M. A.; Cano, S.; Fuentes, M.; Gómez de la Concha, E.; Fernández-‐
Gutiérrez, B; et al. Association between shared epitope and anti-‐citrullinated peptide
antibodies in rheumatoid arthritis: A systematic review and meta-‐analysis. Inmunología
30, 119-‐127(2011).
18. O`Rielly, D. D.; Rahman, P. Pharmacogenetics of rheumatoid arthritis: Potential targets
from susceptibility genes and present therapies. Pharmacogenomics and Personalized
Medicine3, 15-‐31(2010).
19. Karlson, E. W.; Deane, K. Environmental and gene-‐environment interactions and risk of
rheumatoidarthritis. RheumDisClinNorthAm38, 405-‐426(2012).
20. Somers, E. C.; Thomas, S. L.; Smeeth, L.; Hall, A. J. Autoimmunediseases co-‐occurringwithin
individuals andwithin families: a systematic review. Epidemiology17,202-‐217(2006).
21. Goemaere, S.; Ackerman, C; Goethals, K.; DeKeyser, F.; Vander Straeten, C.; Verbruggen; G.;
et al. Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal
transition. JRheumatol 17, 1620-‐1622(1990).
22. Jacobsson, L. T.; Jacobsson, M.E.; Askling, J.; Knowler, W. C. Perinatal characteristics and
riskof rheumatoidarthritis. BMJ 326, 1068-‐1069(2003).
23. Feitsma, A. L.;Worthington, J.; vanderHelm-‐vanMil, A. H.; Plant, D.; Thomson,W.; Ursum,
J.; et al. Protective effect of noninherited maternal HLA-‐DR antigens on rheumatoid
arthritisdevelopment. ProcNatl AcadSciUSA104, 19966-‐19970(2007).
24. Sugiyama, D.; Nishimura, K.; Tamaki, K.; Tsuji, G.; Nakazawa, T.; Morinobu, A.; et al. Impact
of smoking as a risk factor for developing rheumatoid arthritis: a meta-‐analysis of
observational studies. Annalsof theRheumaticDiseases69,70-‐81(2010).
25. Klareskog, L.; Stolt, P.; Lundberg, K.; Kallberg, H.; Bengtsson, C.; Grunewald, J.; et al. Anew
model for an etiology of rheumatoid arthritis: smoking may trigger HLA-‐DR (shared
epitope)-‐restricted immune reactions to autoantigensmodified by citrullination. Arthritis
Rheum54, 38-‐46(2006).
26. Saevarsdottir, S.;Wedren, S.; Seddighzadeh,M.; Bengtsson, C.;Wesley, A.; Lindblad, S.; et al.
Patientswithearly rheumatoidarthritiswhosmokeare less likely torespond to treatment
with methotrexate and tumor necrosis factor inhibitors: observations from the
